Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.56 USD 6.63% Market Closed
Market Cap: 554.4m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mind Medicine (MindMed) Inc
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Other Current Liabilities
$22.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Other Current Liabilities
$102m
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-3%
Sundial Growers Inc
NASDAQ:SNDL
Other Current Liabilities
CA$4.4m
CAGR 3-Years
122%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Other Current Liabilities
$440k
CAGR 3-Years
-86%
CAGR 5-Years
-79%
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Other Current Liabilities
CA$9.8m
CAGR 3-Years
-18%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Other Current Liabilities
$298.1m
CAGR 3-Years
75%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Mind Medicine (MindMed) Inc
Glance View

Market Cap
554.4m USD
Industry
Pharmaceuticals

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

MNMD Intrinsic Value
3.7 USD
Overvaluation 51%
Intrinsic Value
Price

See Also

What is Mind Medicine (MindMed) Inc's Other Current Liabilities?
Other Current Liabilities
22.3m USD

Based on the financial report for Sep 30, 2024, Mind Medicine (MindMed) Inc's Other Current Liabilities amounts to 22.3m USD.

What is Mind Medicine (MindMed) Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 1Y
65%

Over the last year, the Other Current Liabilities growth was 65%.

Back to Top